MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.71711

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

Exploring longitudinal relationships among Alzheimer's disease biomarkers.

Saef Benjamin, Petersen Kellen K, Volluz Katherine, Li Yan, Tosun Duygu, Mila-Aloma Marta, Shaw Leslie M, Zetterberg Henrik, Dage Jeffrey L, Rubel Carrie E, Ferber Kyle, Du-Cuny Lei, Coomaraswamy Janaky, Baratta Michael, Mordashova Yulia, Saad Ziad S, Triana-Baltzer Gallen, Ashton Nicholas J, Meyers Emily A, Rosenbaugh Erin G, Sabandal J Martin, Bannon Anthony W, Potter William Z, Alzheimer's Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer's Disease Project Team, Schindler Suzanne E

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

While most studies of Alzheimer's disease (AD) examine cross-sectional relationships among biomarkers, longitudinal relationships are also highly relevant.

METHODS

This study in the Alzheimer's Disease Neuroimaging Initiative cohort (n = 373) used non-parametric Spearman correlations to explore the relationships of baseline values and rates of change in plasma biomarkers and rates of change in key AD outcomes.

RESULTS

Compared to rates of change of plasma biomarkers, baseline values of plasma biomarkers were more strongly associated with rates of change in key AD outcomes. Change in amyloid positron emission tomography (PET) was most strongly associated with baseline values of amyloid beta (Aβ)42/Aβ40 and phosphorylated tau (p-tau)217, especially in amyloid PET--negative individuals. Changes in cortical thickness and measures of cognition were most strongly associated with baseline p-tau217, especially in amyloid PET-positive individuals.

DISCUSSION: Baseline p-tau217 is associated with rates of change of amyloid pathology and cognition. Visualization tools were developed to enable researchers to explore AD biomarker relationships.

Для цитирования: Saef Benjamin, Petersen Kellen K, Volluz Katherine, Li Yan, Tosun Duygu, Mila-Aloma Marta, Shaw Leslie M, Zetterberg Henrik, Dage Jeffrey L, Rubel Carrie E, Ferber Kyle, Du-Cuny Lei, Coomaraswamy Janaky, Baratta Michael, Mordashova Yulia, Saad Ziad S, Triana-Baltzer Gallen, Ashton Nicholas J, Meyers Emily A, Rosenbaugh Erin G, Sabandal J Martin, Bannon Anthony W, Potter William Z, Alzheimer's Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer's Disease Project Team, Schindler Suzanne E. Exploring longitudinal relationships among Alzheimer's disease biomarkers.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2026. DOI: 10.1002/alz.71711.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.